MET.NYSEMetlife INC

10-K: MetLife Outlines Securities and Governance in 10-K Filing

Sentiment:

Securities Description


MetLife's 10-K filing details the company's registered securities, dividend policies, corporate governance, and preferred stock terms.

Summary

  • MetLife has 3,000,000,000 authorized shares of common stock and 200,000,000 authorized shares of preferred stock.
  • As of February 8, 2024, there were 723,020,313 shares of common stock outstanding.
  • MetLife has six classes of securities registered under the Securities Exchange Act of 1934, including common stock and several series of preferred stock.
  • Holders of common stock are entitled to dividends as determined by the board of directors, but there is no assurance of dividend payments.
  • The company's preferred stock series include Series A, D, E, F, and G, each with specific dividend rates and liquidation preferences.
  • The Series A Preferred Shares have a floating dividend rate based on three-month CME Term SOFR plus 1.00% and 0.26161% or 4.00%, whichever is greater.
  • The Series D Preferred Shares have a fixed rate of 5.875% until March 15, 2028, and a floating rate of three-month CME Term SOFR plus 3.22061% thereafter.
  • The Series E Preferred Shares have a fixed dividend rate of 5.625%.
  • The Series F Preferred Shares have a fixed dividend rate of 4.75%.
  • The Series G Preferred Shares have a fixed rate of 3.850% until September 15, 2025, and a floating rate based on the five-year treasury rate plus 3.576% thereafter.
  • The document outlines various provisions in MetLife's certificate of incorporation and by-laws that may have an anti-takeover effect.
  • The MetLife Policyholder Trust holds 116,905,555 shares of common stock as of February 8, 2024, and its voting provisions may affect the outcome of stockholder votes.
  • The Series A Preferred Shares have certain dividend restrictions based on the company's risk-based capital ratio and adjusted shareholders equity amount.
  • The Series A, D, E, F and G Preferred Shares have voting rights in the event of non-payment of dividends for six or more dividend periods.
  • The Series A, D, E, F and G Preferred Shares are redeemable at the company's option, subject to regulatory approval.

Sentiment

Score: 7

Explanation: The document is factual and descriptive, with no strong positive or negative sentiment. It provides necessary information for investors to understand the company's securities and governance structure.

Positives

  • The document provides a detailed description of the company's capital structure and the rights of different classes of shareholders.
  • The document outlines the dividend policies for both common and preferred stock, providing transparency to investors.
  • The document details the terms of various series of preferred stock, including dividend rates, liquidation preferences, and voting rights.
  • The document provides information about the MetLife Policyholder Trust and its potential impact on stockholder votes.
  • The document outlines the redemption options for the various series of preferred stock.

Negatives

  • The document includes provisions that may have an anti-takeover effect, which could discourage potential acquisitions.
  • The document notes that there is no assurance of dividend payments on common stock.
  • The Series A Preferred Shares have certain dividend restrictions based on the company's risk-based capital ratio and adjusted shareholders equity amount, which could limit dividend payments.
  • The document notes that the board of directors will effectively be able to control votes on all matters submitted to a vote of stockholders, excluding those fundamental corporate actions, so long as the trust holds a substantial number of shares of our common stock.

Risks

  • The document outlines provisions in MetLife's certificate of incorporation and by-laws that may have an anti-takeover effect, potentially discouraging future takeover attempts.
  • The document notes that the declaration and payment of common stock dividends will depend on various factors, including financial condition and regulatory restrictions, and there is no assurance of dividend payments.
  • The document states that the Series A Preferred Shares have certain dividend restrictions based on the company's risk-based capital ratio and adjusted shareholders equity amount, which could limit dividend payments.
  • The document notes that the board of directors will effectively be able to control votes on all matters submitted to a vote of stockholders, excluding those fundamental corporate actions, so long as the trust holds a substantial number of shares of our common stock.

Future Outlook

The remaining shares of authorized and unissued common stock will be available for future issuance without additional stockholder approval.

Industry Context

This document is a standard securities description and corporate governance disclosure, which is common for publicly traded companies. The specific terms of the preferred stock and the anti-takeover provisions are specific to MetLife.

Comparison to Industry Standards

  • The structure of MetLife's preferred stock offerings, with varying fixed and floating rates, is common among financial institutions seeking to manage their capital structure.
  • The use of a floating rate based on the CME Term SOFR is a standard practice in the current market environment.
  • The anti-takeover provisions outlined in the document are similar to those found in the corporate governance documents of other large public companies.
  • The dividend restrictions based on risk-based capital ratios and adjusted shareholders equity are common among insurance companies to ensure financial stability.
  • The voting rights of preferred stockholders in the event of non-payment of dividends are a standard feature of preferred stock offerings.

Stakeholder Impact

  • Shareholders are provided with detailed information about their rights and the company's capital structure.
  • Potential investors can use this document to assess the risks and rewards of investing in MetLife's securities.
  • The document outlines the company's dividend policies, which are important for income-seeking investors.
  • The document provides transparency about the company's corporate governance practices.

Key Dates

DateDescription
September 1999Metropolitan Life Insurance Company converted from a mutual life insurance company to a stock life insurance company subsidiary of MetLife.
April 5, 2000MetLife, Inc.'s common stock began trading on the New York Stock Exchange.
April 4, 2010The stockholder rights plan related to the Series A Junior Preferred Shares expired.
June 15, 2023Date after which the Series E Preferred Shares are redeemable at a redemption price of $25,000 per share.
March 15, 2025Date after which the Series F Preferred Shares are redeemable at a redemption price of $25,000 per share.
September 15, 2025The First Reset Date for the Series G Preferred Shares.
March 15, 2028Date after which the Series D Preferred Shares have a floating dividend rate.
February 8, 2024Date of share information provided in the document.

Keywords

common stock, preferred stock, dividends, voting rights, liquidation preference, MetLife Policyholder Trust, corporate governance, anti-takeover, redemption, CME Term SOFR

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.